ALLMedicine™ Acneiform Eruptions Center
Research & Reviews 73 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793452
Medicine He C, Lin R et. al.
Jan 12th, 2021 - Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poo...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.
Oct 11th, 2020 - Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.
Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.
Mar 9th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.
Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.
Clinicaltrials.gov 77 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793452
Medicine He C, Lin R et. al.
Jan 12th, 2021 - Acneiform eruptions from epidermal growth factor receptor tyrosine kinase inhibitors is a frequent adverse event in non-small cell lung cancer patients but the efficacy of its treatment including antibiotics, corticosteroid, sunscreen is still poo...
https://doi.org/10.1016/j.jaad.2020.09.090
Journal of the American Academy of Dermatology; Costello CM, Hill HE et. al.
Oct 11th, 2020 - Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.|2020|Costello CM,Hill HE,Brumfiel CM,Yang YW,Swanson DL,|
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.
Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.
Mar 9th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.
Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.
News 5 results
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.
Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.
https://www.mdedge.com/dermatology/article/68432/acne/acneiform-eruptions-induced-epidermal-growth-factor-receptor
Requena C, Llombart B et. al.
Aug 1st, 2012
https://www.mdedge.com/dermatology/article/66493/acne/acneiform-eruptions
Kuflik JH, Schwartz RA
No abstract available.
https://www.medscape.com/viewarticle/742542
Abstract and Introduction Abstract Epidermal growth factor receptor (EGFR) inhibitors are an increasingly important treatment option for metastasized cancer in patients. In addition to the pivotal role of EGFR in the development and progression of...
https://www.medscape.com/viewarticle/742542_7
Conclusion EGFR inhibitors are associated with a unique group of class- specific cutaneous toxicities, which include acneiform eruptions, paronychia, xerosis, hyperpigmentation, trichomegaly, and telangiectasia. As the use of EGFR inhibitors incre...